MedPath

Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors

Not Applicable
Active, not recruiting
Conditions
Cancer Survivor
Breast Cancer
Interventions
Other: educational intervention
Procedure: standard follow-up care
Other: counseling intervention
Procedure: quality-of-life assessment
Other: questionnaire administration
Registration Number
NCT01824745
Lead Sponsor
City of Hope Medical Center
Brief Summary

This randomized pilot clinical trial studies survivorship care planning in improving the quality of life in breast cancer survivors. Survivorship care planning may reduce stress and improve the well-being and quality of life of cancer survivors.

Detailed Description

PRIMARY OBJECTIVES:

I. Test the effectiveness of the navigation intervention and survivorship care plan (SCP)-breast cancer survivors (BCS) template booklet on accessing and adhering to SCP-BCS guidelines compared to the control group receiving usual care and the SCP-BCS template booklet.

SECONDARY OBJECTIVES:

I. Develop a clinically and psychosocially responsive SCP-breast cancer survivors (SCP-BCS) template in English and English-Spanish adopted from American Society of Clinical Oncology (ASCO)-SCP.

II. Assess the acceptability, utility and format preference (electronic vs paper) of the SCP-BCS template.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.

ARM II: Participants receive SCP-BCS template booklet and receive standard follow-up care.

After completion so study treatment, participants are followed up at 6 and 12 months.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • In early survivorship phase, defined as being post-surgery to ending of active treatment to 18 months post active treatment for stage 0-3 breast cancer (BCA)
  • Reside in Southern California
  • BCS treated at Kaiser, an health maintenance organization (HMO) provider, will be excluded since their SCP implementation project is underway
  • BCS will not be excluded based on cancer treatments received or a history of diagnosis of mild depression, anxiety, and hypertension and diabetes
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm I (SCP-BCS template booklet and counseling)quality-of-life assessmentParticipants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.
Arm II (SCP-BCS template booklet)educational interventionParticipants receive SCP-BCS template booklet and receive standard follow-up care.
Arm II (SCP-BCS template booklet)standard follow-up careParticipants receive SCP-BCS template booklet and receive standard follow-up care.
Arm I (SCP-BCS template booklet and counseling)counseling interventionParticipants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.
Arm II (SCP-BCS template booklet)quality-of-life assessmentParticipants receive SCP-BCS template booklet and receive standard follow-up care.
Arm II (SCP-BCS template booklet)questionnaire administrationParticipants receive SCP-BCS template booklet and receive standard follow-up care.
Arm I (SCP-BCS template booklet and counseling)educational interventionParticipants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.
Arm I (SCP-BCS template booklet and counseling)questionnaire administrationParticipants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.
Primary Outcome Measures
NameTimeMethod
Proportion of BCS accessing a SCP from their oncology providerAt 6 months

Fisher's exact test will be used to test the null hypothesis (at least 40% of trial participants will have access to SCP).

Secondary Outcome Measures
NameTimeMethod
Proportion of BCS accessing a SCP from their oncology providerAt 12 months

Fisher's exact test will be used to test the null hypothesis (at least 60% of trial participants will have access to SCP).

Adherence to SCP guidelinesAt 12 months

Fisher's exact test will be used to test the null hypothesis (at least 25% of participants reporting adherence to SCP guidelines).

Trial Locations

Locations (2)

City of Hope Antelope Valley

🇺🇸

Lancaster, California, United States

City of Hope Medical Center

🇺🇸

Duarte, California, United States

© Copyright 2025. All Rights Reserved by MedPath